Clovis Oncology, Inc. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Clovis Oncology, Inc. for September 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 30,938 | |
Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 32.21 | 1,728 | 55,659 | 13,821 | 15.5 K to 13.8 K (-11.11 %) |
Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 15,549 | 12.1 K to 15.5 K (+28.38 %) |
Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 16,875 | |
Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 32.21 | 829 | 26,702 | 185,777 | 186.6 K to 185.8 K (-0.44 %) |
Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 186,606 | 184.7 K to 186.6 K (+1.01 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,688 | |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 35.75 | 212 | 7,579 | 5,074 | 5.3 K to 5.1 K (-4.01 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,286 | 4.8 K to 5.3 K (+9.74 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,250 | |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 35.75 | 321 | 11,476 | 12,112 | 12.4 K to 12.1 K (-2.58 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 12,433 | 11.8 K to 12.4 K (+5.29 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,250 | |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 35.75 | 282 | 10,082 | 184,731 | 185 K to 184.7 K (-0.15 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 185,013 | 184.4 K to 185 K (+0.34 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,688 | |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 35.75 | 239 | 8,544 | 5,349 | 5.6 K to 5.3 K (-4.28 %) |
Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,588 | 5.1 K to 5.6 K (+9.16 %) |